Stellar Pharmaceuticals Shows Strong Third Quarter Revenue Growth to $3.2 ...

13-11-2012 StockhouseComments (0)

Pharmaceutical

13, 2012) - Stellar Pharmaceuticals Inc. (OTCQB:SLXCF)(OTCBB:SLXCF)(PINKSHEETS:SLXCF) ("Stellar" or "the Company"), a specialty pharmaceutical company with a primary focus on the acquisition, licensing, development and promotion of healthcare ...

Read more on Stockhouse

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top